Delcath Systems, Inc. (DCTH)
-NasdaqCM 0.48 
0.02(5.32%) 3:22PM EDT - Nasdaq Real Time Price
| Prev Close: | 0.45 |
|---|
| Open: | 0.45 |
|---|
| Bid: | 0.47 x 300 |
|---|
| Ask: | 0.47 x 200 |
|---|
| 1y Target Est: | 0.85 |
|---|
| Beta: | 2.92 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.45 - 0.50 |
|---|
| 52wk Range: | 0.38 - 2.38 |
|---|
| Volume: | 1,125,497 |
|---|
| Avg Vol (3m): | 2,996,290 |
|---|
| Market Cap: | 43.31M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Delcath Systems, Inc., Amyris, Inc., Nam Tai Electronics, Inc. and Accretive Health, Inc.Business Wire(Tue, Jun 18)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandEDGAR Online(Tue, Jun 18)
- Saxena White P.A. Files Securities Fraud Class Action Against Delcath Systems, Inc.Marketwired(Mon, Jun 17)
- Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc.Business Wire(Mon, Jun 17)
- Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTHGlobeNewswire(Fri, Jun 14)
- 5 Stocks Under $10 Set to Soarat TheStreet(Thu, Jun 13)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Other EventsEDGAR Online(Fri, Jun 7)
- The Rosen Law Firm Reminds Delcath Investors of Important Class Action Deadline -- DCTHGlobeNewswire(Wed, Jun 5)
- Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTHGlobeNewswire(Fri, May 31)
- Lifshitz Law Firm Announces Investigation of Aruba Networks, Inc., Delcath Systems, Inc., and Digital Generation, Inc.PR Newswire(Tue, May 28)
- Record Use of At-the-Market (ATM) Offerings Continues in 2013 with $161 Million Raised by U.S. Life Sciences Companies in First Quarter, Reports Brinson PatrickPR Newswire(Tue, May 28)
- Law Offices of Todd M. Garber Announces Investigation of Delcath Systems, Inc.Business Wire(Sat, May 25)
- DELCATH SYSTEMS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Tue, May 21)
- SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 from Investment in Delcath Systems, Inc. to Contact Brower Piven Before the July 8, 2013 Lead Plaintiff DeadlineBusiness Wire(Mon, May 20)
- Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Delcath Systems, Inc.Business Wire(Mon, May 20)
Press Releases
- Investor Alert: Holzer Holzer & Fistel, LLC Advises Investors of Upcoming Deadlines in Shareholder Litigation Involving Delcath Systems, Inc., Amyris, Inc., Nam Tai Electronics, Inc. and Accretive Health, Inc.Business Wire(Tue, Jun 18)
- Saxena White P.A. Files Securities Fraud Class Action Against Delcath Systems, Inc.Marketwired(Mon, Jun 17)
- Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc.Business Wire(Mon, Jun 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 56.56 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.42 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.11 |
|---|
| Mean Recommendation*: | 3.5 |
|---|
| PEG Ratio (5 yr expected): | -0.07 |
|---|
Business Summary
Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology. The companys proprietary technology enables the administration of high-dose chemotherapy and other therapeutic agents ...
View More